Thalidomide Maintenance in Multiple Myeloma: Certainties and Controversies Reply

被引：1
|
作者：
Spencer, Andrew [1 ]
Prince, H. Miles [2 ]
Roberts, Andrew W. [3 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 32期
关键词：
CONSOLIDATION THERAPY; SURVIVAL;
D O I：
10.1200/JCO.2009.24.0853
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [31] The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma-A report by the Polish Myeloma Study Group
    Dmoszynska, Anna
    Walter-Croneck, Adam
    Hus, Iwona
    Grzasko, Norbert
    Manko, Joanna
    Jedrzejczak, Wieslaw Wiktor
    Charlinski, Grzegorz
    Usnarska-Zubkiewicz, Lidia
    Skotnicki, Aleksander
    Wolska-Smolen, Teresa
    Piszcz, Jaroslaw
    Kloczko, Janusz
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1330 - 1335
  • [32] The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
    Kim, Cheolsu
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je Jung
    Kim, Kihyun
    Yoon, Dok Hyun
    Eom, Hyeon Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (05) : 675 - 683
  • [33] Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Gutierrez, Norma
    Teruel, Ana-Isabel
    Lopez de la Guia, Ana
    Lopez, Javier
    Bengoechea, Enrique
    Perez, Montserrat
    Polo, Marta
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose-Mariano
    Granell, Miquel
    Bello, Jose-Luis
    Bargay, Joan
    Penalver, Francisco-Javier
    Ribera, Jose-Maria
    Martin-Mateos, Maria-Luisa
    Garcia-Sanz, Ramon
    Lahuerta, Juan-Jose
    Blade, Joan
    San-Miguel, Jesus F.
    BLOOD, 2012, 120 (13) : 2581 - 2588
  • [34] Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma
    Cornell, Robert F.
    D'Souza, Anita
    Kassim, Adetola A.
    Costa, Luciano J.
    Innis-Shelton, Racquel D.
    Zhang, Mei-Jie
    Huang, Jiaxing
    Abidi, Muneer
    Aiello, Jack
    Akpek, Gorgun
    Bashey, Asad
    Bashir, Qaiser
    Cerny, Jan
    Comenzo, Raymond
    Angel Diaz, Miguel
    Freytes, Cesar
    Gale, Robert Peter
    Ganguly, Siddhartha
    Hamadani, Mehdi
    Hashmi, Shahrukh
    Holmberg, Leona
    Hossain, Nasheed
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed
    Kindwall-Keller, Tamila
    Kyle, Robert
    Kumar, Shaji
    Lazarus, Hillard
    Lee, Cindy
    Maiolino, Angelo
    Marks, David I.
    Meehan, Kenneth
    Mikhael, Joe
    Nath, Rajneesh
    Nishihori, Taiga
    Olsson, Richard F.
    Ramanathan, Muthalagu
    Saad, Ayman
    Seo, Sachiko
    Usmani, Saad
    Vesole, David
    Vij, Ravi
    Vogl, Dan
    Wirk, Baldeep M.
    Yared, Jean
    Krishnan, Amrita
    Mark, Tomer
    Nieto, Yago
    Hari, Parameswaran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 269 - 277
  • [35] Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population
    Ludwig, Heinz
    Poenisch, Wolfram
    Knop, Stefan
    Egle, Alexander
    Hinke, Axel
    Schreder, Martin
    Lechner, Daniel
    Hajek, Roman
    Gunsilius, Eberhard
    Petzer, Andreas
    Weisel, Katja
    Niederwieser, Dietger
    Einsele, Hermann
    Willenbacher, Wolfgang
    Rumpold, Holger
    Pour, Ludek
    Jelinek, Tomas
    Krenosz, Karl Jochen
    Meckl, Angela
    Nolte, Sandra
    Melchardt, Thomas
    Greil, Richard
    Zojer, Niklas
    LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 377 - 386
  • [36] Maintenance treatment after autologous stem cell transplantation in patients with multiple myeloma - new drugs for multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S4
  • [37] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Li, Ang
    Wu, Qian
    Warnick, Greg
    Li, Shan
    Libby, Edward N.
    Garcia, David A.
    Lyman, Gary H.
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 121 - 126
  • [38] Maintenance therapy in newly diagnosed multiple myeloma: current recommendations
    Brioli, Annamaria
    Tacchetti, Paola
    Zamagni, Elena
    Cavo, Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 581 - 594
  • [39] Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma
    Nunnelee, Jordan
    Cottini, Francesca
    Zhao, Qiuhong
    Faisal, Muhammad Salman
    Elder, Patrick
    Rosko, Ashley
    Bumma, Naresh
    Khan, Abdullah
    Umyarova, Elvira
    Devarakonda, Srinivas
    Benson, Don M.
    Efebera, Yvonne A.
    Sharma, Nidhi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [40] Limite d b enefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea
    Byun, Ja Min
    Kim, Sang-A
    Koh, Youngil
    Shin, Dong-Yeop
    Kwon, Ji Hyun
    Kim, Jin Seok
    Kim, Kihyun
    Min, Chang-Ki
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Bang, Soo-Mee
    Yoon, Sung-Soo
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
12345